Drug discovery beyond the ‘rule-of-five’
- 31 December 2007
- journal article
- review article
- Published by Elsevier BV in Current Opinion in Biotechnology
- Vol. 18 (6), 478-488
- https://doi.org/10.1016/j.copbio.2007.10.005
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- A decade of fragment-based drug design: strategic advances and lessons learnedNature Reviews Drug Discovery, 2007
- Studies Leading to Potent, Dual Inhibitors of Bcl-2 and Bcl-xLJournal of Medicinal Chemistry, 2007
- Pharma faces major challenges after a year of failures and heated battlesNature Reviews Drug Discovery, 2007
- How many drug targets are there?Nature Reviews Drug Discovery, 2006
- Direct thrombin inhibitors – a survey of recent developmentsCellular and Molecular Life Sciences, 2006
- Progress in identifying peptides and small-molecule inhibitors targeted to gp41 of HIV-1Expert Opinion on Investigational Drugs, 2006
- Drug research: myths, hype and realityNature Reviews Drug Discovery, 2003
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsAdvanced Drug Delivery Reviews, 2001
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsAdvanced Drug Delivery Reviews, 1997
- HIV-1 inhibition by a peptideNature, 1993